Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Goodwill (2016 - 2025)

United Therapeutics' Goodwill history spans 15 years, with the latest figure at $32.3 million for Q4 2025.

  • For Q4 2025, Goodwill changed 0.0% year-over-year to $32.3 million; the TTM value through Dec 2025 reached $32.3 million, changed 0.0%, while the annual FY2025 figure was $32.3 million, 0.0% changed from the prior year.
  • Goodwill for Q4 2025 was $32.3 million at United Therapeutics, roughly flat from $32.3 million in the prior quarter.
  • Across five years, Goodwill topped out at $32.3 million in Q4 2025 and bottomed at $4.3 million in Q3 2024.
  • The 4-year median for Goodwill is $28.0 million (2021), against an average of $25.5 million.
  • The largest annual shift saw Goodwill changed 0.0% in 2021 before it rose 0.0% in 2025.
  • A 4-year view of Goodwill shows it stood at $28.0 million in 2021, then changed by 0.0% to $28.0 million in 2022, then increased by 15.36% to $32.3 million in 2024, then rose by 0.0% to $32.3 million in 2025.
  • Per Business Quant, the three most recent readings for UTHR's Goodwill are $32.3 million (Q4 2025), $32.3 million (Q4 2024), and $4.3 million (Q3 2024).